Literature DB >> 15922731

Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization.

Stephanie J Beech1, Katherine J Lethbridge, Neil Killick, Nicholas McGlincy, Keith N Leppard.   

Abstract

The PML protein is a defining constituent of subnuclear structures known as ND10. PML is expressed as a series of primary sequence isoforms through alternative RNA processing. Expression of each of six distinct PML isoforms that differed in their C-terminal domains caused reproducible differences in the number, size, and shape of ND10 in both transformed cell lines and diploid fibroblasts. In each case, PML from the endogenous genes was reorganized to participate with the exogenously expressed PML in the new configuration of ND10. Variation in ND10 number is known to occur during the cell cycle; however, the cell cycle distribution of the transfected cells that displayed these altered ND10 was similar for all six PML isoforms. Given our findings, the precise level of expression of the different PML isoforms under particular physiological conditions will be an important determinant of ND10 organization and function and is a potential point of regulation of PML/ND10 function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922731     DOI: 10.1016/j.yexcr.2005.03.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  19 in total

Review 1.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

2.  Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Authors:  Yunyun Geng; Shamci Monajembashi; Anwen Shao; Di Cui; Weiyong He; Zhongzhou Chen; Peter Hemmerich; Jun Tang
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

3.  Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.

Authors:  Gregory J Block; Christopher H Eskiw; Graham Dellaire; David P Bazett-Jones
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

4.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination.

Authors:  Percy Luk Yeung; Natalia G Denissova; Cara Nasello; Zhanna Hakhverdyan; J Don Chen; Mark A Brenneman
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

6.  PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.

Authors:  Delphine Cuchet; Amanda Sykes; Armel Nicolas; Anne Orr; Jill Murray; Hüseyin Sirma; Joerg Heeren; Alexander Bartelt; Roger D Everett
Journal:  J Cell Sci       Date:  2010-12-20       Impact factor: 5.285

7.  SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress.

Authors:  Yan Han; Chao Huang; Xuxu Sun; Binggang Xiang; Ming Wang; Edward T H Yeh; Yuying Chen; Hui Li; Guiying Shi; Hui Cang; Yueping Sun; Jian Wang; Wei Wang; Fei Gao; Jing Yi
Journal:  J Biol Chem       Date:  2010-02-24       Impact factor: 5.157

8.  Gamma interferon-dependent transcriptional memory via relocalization of a gene locus to PML nuclear bodies.

Authors:  Manolis Gialitakis; Panagiota Arampatzi; Takis Makatounakis; Joseph Papamatheakis
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

9.  Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus.

Authors:  Diane C Munday; Edward Emmott; Rebecca Surtees; Charles-Hugues Lardeau; Weining Wu; W Paul Duprex; Brian K Dove; John N Barr; Julian A Hiscox
Journal:  Mol Cell Proteomics       Date:  2010-07-20       Impact factor: 5.911

10.  Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus.

Authors:  Tomomi Nakahara; Paul F Lambert
Journal:  Virology       Date:  2007-06-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.